---
title: "WXXWY.US (WXXWY.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/WXXWY.US/news.md"
symbol: "WXXWY.US"
name: "WXXWY.US"
parent: "https://longbridge.com/en/quote/WXXWY.US.md"
datetime: "2026-05-19T18:56:30.404Z"
locales:
  - [en](https://longbridge.com/en/quote/WXXWY.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/WXXWY.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/WXXWY.US/news.md)
---

# WXXWY.US (WXXWY.US) — Related News

### [07:00 ETEarendil Labs Announces First Cohort Dosed in Phase I Study of Novel Biparatopic Antibody Targeting Thymic Stromal Lymphopoietin (TSLP)](https://longbridge.com/en/news/286758957.md)
*2026-05-18T11:00:40.000Z*
> Earendil Labs has announced the successful dosing of the first cohort in a Phase I clinical trial for HXN-1011, a novel 

### [WuXi AppTec's net profit attributable to shareholders in the first quarter was 4.652 billion yuan, a year-on-year increase of 26.68%](https://longbridge.com/en/news/284178123.md)
*2026-04-27T08:43:13.000Z*
> WuXi AppTec announced that in the first quarter of 2026, it achieved operating revenue of 12.44 billion yuan, a year-on-

### [WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Update](https://longbridge.com/en/news/284068242.md)
*2026-04-25T03:13:58.000Z*
> WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) experienced a significant decline in short interest, dropping 82.6% to 24,4

### [07:03 ETWuXi Biologics Chengdu Microbial Commercial Manufacturing Site Achieves Structural Completion and Key Equipment Arrival](https://longbridge.com/en/news/283987372.md)
*2026-04-24T11:05:38.000Z*
> WuXi Biologics has announced the structural completion and arrival of key equipment at its microbial commercial manufact

### [02:14 ETWuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics](https://longbridge.com/en/news/283774356.md)
*2026-04-23T06:15:39.000Z*
> WuXi Biologics has received GMP certification from South Korea's MFDS for three of its manufacturing facilities, enablin

### [A Look At WuXi Biologics (SEHK:2269) Valuation After Securing ISO 13485:2016 Certification](https://longbridge.com/en/news/283038681.md)
*2026-04-16T17:52:02.000Z*
> WuXi Biologics (SEHK:2269) has secured ISO 13485:2016 certification for its medical device quality management system, hi

### [22:39 ETWuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug-Device Combination Product Development and Manufacturing](https://longbridge.com/en/news/282772645.md)
*2026-04-15T02:40:43.000Z*
> WuXi Biologics has achieved ISO 13485:2016 certification, becoming one of the first in China's drug-device combination p